Aim: Highly concentrated carbon dioxide (CO2) is thought to be useful for ischemic diseases. We investigated whether treatment with a few micrometers of CO2 molecules atomized via two fluidnozzles (CO2 mist) exerts an angiogenic effect in a mouse ischemic hindlimb model. Methods: Mice with unilateral hindlimb ischemia were divided into untreated (UT), 100% CO2 gas alone-treated (CG), mixed air (O2; 20%, N2; 80%) mist-treated (AM) and 100% CO2 mist-treated (CM) groups. The lower body of the mice was encased in a polyethylene bag filled with each gaseous agent using a gas mist generator for 10 minutes daily. Results: According to a laser Doppler analysis, the ischemic hindlimb blood flow was persistently higher after the seventh day of induction of ischemia in the CM group than in the UT group. The capillary density was also greater in the CM group on day 28 compared with that observed in the UT group. In addition, the parameters in the AM and CG groups were similar to those obtained in the UT group. The observed effects were abolished by the administration of an inhibitor of nitric oxide synthase (NOS). The vascular endothelial growth factor mRNA expression and protein levels and the phosphorylated endothelial NOS level were increased in the CM group compared with that observed in the UT group. A proteomic analysis using liquid chromatography-tandem mass spectrometry identified novel protein candidates regulated by CO2 mist. Conclusion: Percutaneous CO2 mist therapy may be useful for treating ischemia-induced angiogenesis.
Introduction
Patients with peripheral arterial disease (PAD) exhibit greater functional impairment, with a more rapid functional decline and lower physical activity levels in daily life than those without PAD 1, 2) . The treatment of PAD has evolved over the past decade to include a broad approach, focusing on reducing the incidence of adverse cardiovascular events, improving the symptoms of claudication and preventing tissue loss under conditions of critical limb ischemia 3, 4) . Because these subjects have a severely limited quality of life, great emphasis is placed on ameliorating symptoms and reducing the risk of PAD progression. In Yasukatsu Izumi and Takehiro Yamaguchi contributed equally to this work.
care guidelines. The study protocol conformed with the Guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996) . Male Wistar rats and male C57BL/6J (wild-type), inducible NO synthase deficient (iNOS / ) and endothelial NO synthase deficient (eNOS / ) mice 8-10 weeks of age were used in the present study. Unilateral hindlimb ischemia was induced under anesthesia with sodium pentobarbital (50 mg/kg intraperitoneally (i.p.)), as previously described 7, [11] [12] . Mixed air dry mist (AM) and CO2 mist (CM) was generated using a dry mist production unit (Advance Biotron Co., Ltd., Tokyo, Japan) 10) . In brief, 100% concentrated CO2 or mixed air (N2: 80%; O2: 20%) was compounded and compressed with water through double fluid nozzles at 4 atmospheres.
The mice were treated with 100% CO2 gas (CG), AM or CM for 10 minutes once a day in a draft cabinet. Briefly, under anesthesia with sodium pentobarbital, the lower body of each mouse was encased in a sealed polyethylene bag on a heating plate at 37 . The polyethylene bag was then filled with CG, AM or CM in the draft cabinet. The untreated (UT) group was kept on the heating plate at 37 for 10 minutes once a day under anesthesia. The use of 100% CO2 at 4 units of barometric pressure resulted in a CO2 concentration in the bag of approximately 900,000 ppm 10) .
Effects of CO2 Mist on the Vasodilation of Microvessels and Tissue Blood Flow
The first series of experiments was performed to compare the effects of CG, AM and CM on the vasodilation of microvessels. One week after the induction of hindlimb ischemia, the mouse femurs were slightly cut open, exposing the subcutaneous vessels, under anesthesia with sodium pentobarbital (50 mg/kg, i.p.). The incision site was then covered with a transparent seal. We then observed whether the CG or CM treatment dilated the microvessels using a digital microscope (VHX-1000, Keyence Co., Ltd., Osaka, Japan) equipped with a zoom lens.
Next, we investigated the effects of CG and CM on the tissue blood flow. At one week after the induction of hindlimb ischemia in the rats, we measured the blood flow in the shallow region of the tissue using laser tissue blood oxygenation monitors and nearinfrared spectroscopy (BOM-L1TR SF, Omegawave Inc., Tokyo, Japan) during treatment with CG or CM. In brief, a saturation-monitoring sensor was attached to the rat toe. Changes in the tissue levels of oxygenated hemoglobin (oxy-Hb), deoxygenated hemoglobin spite of the development of various types of medicines 4) , the frequency of PAD has not yet decreased. Exercise rehabilitation is also recommended in patients with this disease 5) ; however, supervised exercise is not covered by major medical insurance providers. Furthermore, it can be difficult to provide supervised exercise therapy for patients with PAD who are incapable of performing active exercise, such as those with neurodegenerative and rheumatologic diseases or agerelated skeletal muscle wasting. Novel passive exercises, such as thermal therapy and whole-body periodic acceleration therapy, for PAD have been recently received much attention 6, 7) . Balneotherapy using hot springs containing a high concentration of carbon dioxide (CO2) has long been applied clinically to treat a variety of cardiovascular diseases, especially in European countries. The transfer of CO2 across the skin is thought to have beneficial local vasomotor effects without inducing systemic hemodynamic modifications 8) . A recent study demonstrated that the immersion of ischemic mouse hindlimbs into baths of artificially created CO2-enriched water results in a nitric oxide (NO)-dependent increase in collateral blood perfusion as well as the induction of regional vascular endothelial growth factor (VEGF) synthesis 9) . Hence, bathing in CO2-enriched water may be a useful therapeutic approach in patients with PAD. Carbonate spring water is generally defined as water containing more than 1,000 parts per million (ppm) of CO2, although the cost to set up such systems is expensive. Therefore, the development of more simple and affordable systems would be valuable.
Very recently, a new and simple system was developed in which CO2 gas is dissolved in water containing a high concentration of CO2 molecules using two fluid-nozzles, namely, CO2 mist. We previously reported that the CO2 mist produced by this device has a therapeutic benefit in the treatment of heart failure due to myocardial infarction 10) . In the present study, we investigated whether treatment with CO2 mist accelerates angiogenesis in a well-established mouse model of ischemia-induced angiogenesis. Consequently, we obtained evidence that CO2 mist therapy stimulates ischemia-induced revascularization via upregulation of the angiogenic growth factor expression.
Materials and Methods

Animals and Experimental Protocol
All procedures involving animals were performed in compliance with the Osaka City University animal formance liquid chromatography, according to the manufacturer's instructions 10) .
Quantitative Real-Time Polymerase Chain Reaction Total RNA was isolated using ISOGEN (Nippon Gene Co., Ltd., Toyama, Japan). In order to determine the transcript levels of vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF-2), the RNA samples were subjected to quantitative real-time polymerase chain reaction (RT-PCR, 7500 Fast; Applied Biosystems, Carlsbad, CA). Onestep quantitative RT-PCR reactions were performed using 100 ng of total RNA per reaction. The transcript levels were normalized to that of 18S for the analysis.
Effects of a NO Synthase Inhibitor on the Outcomes of CO2 Dry Mist Therapy
In order to chronically inhibit NOS, wild-type mice with hindlimb ischemia were provided water containing 1 mg/mL of N G -nitro-L-arginine methyl ester (L-NAME) for four weeks. Furthermore, iNOS / and eNOS / mice with hindlimb ischemia were treated with CO2 mist for 28 days. The hindlimb blood flow was then measured, as described above.
Effects of a Low Concentration of CO2 on the Tissue Blood Flow
In order to investigate whether blood perfusion is enhanced in a CO2 concentration-dependent manner, we compared the effects of no treatment and treatment with 250,000 ppm (low CM) or 900,000 ppm (high CM) of CO2 in the bags encasing the lower body of the mice. The high or low CM conditions were produced using 100% concentrated CO2 or a mixture of 100% concentrated CO2 and mixed air, respectively. The LDBF analysis was performed as described above.
Mass Analysis
At four days after ischemia, the mice were euthanized under anesthesia with sodium pentobarbital (100 mg/kg, i.p.) and their hindlimbs were removed. Digested proteins (150 g) from the muscles in the non-ischemic, UT and CM groups (pooling of each n 5) were reduced, alkylated, digested with trypsin and labeled with an isobaric tag for use with relative and absolute quantitation (iTRAQ) reagents (AB Sciex, Framingham, MA), according to the manufacturer's instructions, with the following minor modification.
After the labeling reaction (114, non-ischemic; 116, UT; 117, CM), the three samples were pooled (deoxy-Hb), total hemoglobin (total-Hb) and tissue saturation (StO2) compared with that observed at baseline were measured continuously during and after the 10-minute treatment period 10) .
Laser Doppler Blood Flow Analysis
In order to investigate the effects of a long duration of CG, AM or CM treatment on the hindlimb blood flow, mice with induced ischemia were randomly divided into four groups: the UT, CG, AM and CM groups. We performed the same experiment twice and obtained data for a total of a 42 mice. The hindlimb blood flow was assessed under anesthesia with sodium pentobarbital (50 mg/kg, i.p.) using a laser Doppler blood flow (LDBF) analyzer (Moor LDI; Moor Instruments, Devon, UK) before and immediately after surgery and on postoperative days 4, 7, 14, 21 and 28, as previously described 11, 12) . The LDBF analysis was performed before each treatment session on days 4, 7, 14 and 21 and 24 hours after the last treatment. After the scanning blood flow, the stored images were subjected to computer-assisted quantification, and the average flow in the ischemic and non-ischemic limbs was calculated. In order to prevent data variations resulting from the effects of ambient light and temperature, the hindlimb blood flow was expressed as the ratio of the left (ischemic) to the right (non-ischemic) LDBF values.
Capillary Density
At 28 days after surgery, the mice were euthanized under anesthesia with sodium pentobarbital (100 mg/kg, i.p.), and their hindlimbs were removed. The capillary density within the ischemic thigh adductor skeletal muscles was subsequently analyzed in order to obtain specific evidence of vascularity at the level of the microcirculation. Three sections of ischemic muscle were harvested from each animal, sliced and fixed in methanol. The tissues were then embedded in paraffin, and multiple tissue slices of 5 m in thickness were prepared. Capillary endothelial cells (ECs) were identified using immunohistochemical staining with a rat anti-mouse CD31 antibody (Ab) (Pharmingen, CA). Fifteen random microscopic fields from three different sections in each tissue block were examined for the presence of capillary ECs, and the capillary density was expressed as the number of capillaries per high-power field ( 400) 11, 12) .
Measurement of the Nitrate (NO3 ) Levels in the Serum
At 28 days after surgery, the mouse serum nitrate (NO3 ) concentration was measured using high-per-effluent was introduced into the spray chamber through a tapered stainless steel emitter and directly electrosprayed into the QSTAR System ion trap mass spectrometer in the positive mode for the nanoESItandem mass spectrometry (MS/MS) analysis. One sample was run for 150 minutes. Protein identification was performed using the Analyst QS Software 2.0 program (AB Sciex) in the positive-ion mode. Both sets of data were processed using the ProteinPilot Software 2.0.1 package according to the ParagonTM search algorithm (AB Sciex), and the MS/MS data were searched against the NCBI database using a Mus musculus taxonomy filter. The minimum threshold for protein identification was set at a protein score of 1.3, and 10 L of 20% (v/v) trifluoroacetic acid was added to cleave RapiGest (Waters, Milford, MA). The samples were then vortexed, incubated at 37 for one hour and centrifuged. The supernatant was subsequently purified using a cation exchange column (AB Sciex), according to standard procedures.
Next, a proteome analysis was performed using a DiNa-AI nano LC System (KYA Technologies, Tokyo, Japan) coupled with a QSTAR Elite hybrid mass spectrometer (AB Sciex) through a NanoSpray ion source (AB Sciex), as previously described 13) . Briefly, mobile phase A included 98% water (2% acetonitrile [ACN], 0.1% formic acid) and mobile phase B included 70% ACN (0.1% formic acid, 30% water). The column microscope showing the vasodilatory effects of the CO2 gas (A to D) and CO2 mist (E to H) in the femoral subcutaneous tissue. After two minutes of spraying the CO2 mist, microvessels gradually appeared. These microvessels were more prominent after five minutes of spraying the CO2 mist (G) compared with that observed before treatment (E). Bar 100 m. The CO2 mist group had significantly increased oxygenated hemoglobin (Hb) levels (I) and decreased deoxygenated Hb levels (J) compared with the untreated, air mist and CO2 gas groups. The total Hb levels were increased versus baseline in the CO2 gas and CO2 mist groups, but not the untreated and air mist groups (K). The tissue saturation levels were also significantly increased in the CO2 mist (CM) group compared with those observed in the untreated (UT), air mist (AM) and CO2 gas (CG) groups (L). oxy Hb, oxygenated hemoglobin; deoxy Hb, deoxygenated hemoglobin; total Hb, total hemoglobin; StO2, tissue saturation. Each bar represents the mean SEM. p 0.05 vs. UT; p 0.05, CO2 mist vs. CO2 gas. 
Statistical Analysis
All data are presented as the mean standard error of the mean (SEM). Comparisons between two experimental groups were made to test for statistical significance using Student's t -test. Further comparisons between groups were made according to the Tukey-Kramer method using the StatView software program (SAS Institute, Inc., Cary, North Carolina, USA). Differences were considered to be statistically which corresponded to a confidence level above 95% and a false discovery rate of 1%.
Western Blotting
Our detailed methods have been previously described 11, 12) . Protein extracts were obtained from homogenized ischemic or non-ischemic skeletal muscles and electrophoretically transferred to polyvinylidene difluoride membranes (Immobilon-P, Millipore, Billerica, MA). The membranes were then probed with each primary antibody.
Antibodies were obtained from the following sources: anti-Ras-associated protein 1b (Rap1b), superoxide dismutase 2 (SOD2), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), VEGF, FGF-2 ually detected two to five minutes after treatment with the CO2 mist compared with that noted before treatment ( Fig. 1-E to H) . Next, we measured the changes in the relative tissue blood flow during CG, AM and CM treatment ( Fig. 1-I to L) . Rats were used in this experiment because the mice were too small to precisely measure the tissue blood flow. The CM group exhibited increased oxy-Hb levels (1.26-fold; Fig. 1-I) , decreased deoxy-Hb levels (0.83-fold; Fig. 1-J) and increased StO2 levels (1.19-fold; Fig. 1-L) compared with that observed at baseline. Importantly, the CM group exhibited significantly higher oxy-Hb levels than the significant at a value of p 0.05.
Results
Effects of CO2 Mist on Vasodilation and the Tissue Blood Flow
We compared the effects of treatment with CG, AM and CM on vasodilation. Wild-type mice in a transparent acrylic case were treated with CG, AM or CM. Treatment with CG did not change the detection of microvessels compared with that observed before treatment ( Fig. 1-A to D) , nor did AM treatment (data not shown). In contrast, a few microvessels were grad- Fig. 3 . Gene expression levels in the ischemic hindlimbs of the untreated, CO2 gas, air mist-treated and CO2 mist-treated mice.
The bar graph shows each mRNA level corrected for the 18S rRNA level on postoperative day 4 (A), day 7 (B) and day 14 (C). The mean value in the untreated group was set at 1. The VEGF and FGF-2 expression levels were significantly increased by the CO2 mist treatment. VEGF, vascular endothelial growth factor; FGF-2, fibroblast growth factor-2; eNOS, endothelial nitric oxide synthase. Other abbreviations are the same as in the 2-A  and B) , whereas the CG-and AM-treated mice demonstrated no acceleration in the recovery of the blood flow.
Next, we measured the capillary density in histological sections harvested from the ischemic tissues in order to investigate the extent of angiogenesis at the level of the microcirculation (Fig. 2-C) . A quantitative analysis revealed that the capillary density was significantly greater on postoperative day 28 in the CM mice than in the UT mice (Fig. 2-D) .
UT group, as well as the CG and AM groups, after five minute of each treatment. Conversely, the CM group exhibited significantly lower deoxy-Hb levels than the UT, AM and CG groups after five minutes of each treatment. Interestingly, the StO2 levels were also significantly higher in the CM group than in the CG group, although the total-Hb levels in the CM group were similar to those observed in the CG group (Fig. 1-L) .
Laser Doppler Blood Perfusion and Tissue Capillary Density
We subsequently investigated whether treatment with CM accelerates blood flow recovery after ischemia. Immediately after the left femoral artery and vein were resected, the ratio of the ischemic (left) to and C). On the other hand, the eNOS expression was slightly but not significantly increased by CM treatment, whereas treatment with CG did not change the VEGF expression on days 4 and 7, but rather increased the expression on day 14. We also examined the protein levels using a Western blot analysis. As shown in Fig. 4 , the VEGF protein levels were increased in the CM group compared with those observed in the UT group. Meanwhile, the FGF-2 levels tended to be increased in the
Expression of Angiogenic Growth Factors in the Ischemic Hindlimbs
VEGF and FGF-2 are the major cytokines responsible for ischemia-induced angiogenesis and arteriogenesis. Therefore, we examined the expression levels of VEGF and FGF-2 in the ischemic tissues of each group. Consequently, a quantitative RT-PCR analysis showed a significantly greater expression of VEGF on days 4, 7 and 14 and FGF2 on day 4 in the CMtreated mice compared with the UT mice (Fig. 3-A Table 1 -A, some of these proteins were related to signal transduction. In contrast, 21 of the 62 downregulated proteins were upregulated by CM treatment (ratio: 116/117 1.2). As shown in Table 1 -B, some of these proteins were related to metabolic enzymes.
In order to confirm the results of the mass analysis, we investigated the levels of several proteins using Western blotting (Supplemental Fig. 1 ). Consequently, the Rap1b level was remarkably increased by ischemia and subsequently decreased by CM treatment. In addition, the SOD-2 and GAPDH levels were decreased by ischemia and increased by CM treatment.
Discussion
The major findings of the present study are that angiogenesis and blood flow recovery in response to hindlimb ischemia were significantly improved by CO2 mist treatment. Furthermore, we obtained the first evidence that CO2 mist therapy affects both eNOS and VEGF, as well as the glycolytic system. Therefore, CO2 mist treatment accelerates ischemia-induced CM group (p 0.055 vs. UT). In contrast to the mRNA expression, the level of phosphorylated eNOS was significantly increased in the CM group on both days 4 and 14. There were no differences in the actin levels between the groups.
Effects of CO2 Mist Treatment on the NO and NOS Levels
The serum concentration of nitrate was measured at four days after ischemia, as shown in Fig. 5-A . The serum nitrate concentrations were significantly greater in the CM group than in the UT group (p 0.05), whereas the nitrate levels in the CG and AM groups did not differ from the control values.
Next, the effects of the NO signaling pathway were investigated. Consequently, L-NAME completely inhibited the effects of the CM treatment (Fig. 5-B) . Furthermore, the CM treatment significantly increased the LDBF ratio in the iNOS-deficient mice, but not in the eNOS-deficient mice (Fig. 5-C and D) . These results suggest that the actions of CO2 mist in stimulating revascularization in vivo are dependent, at least in part, on eNOS.
Effects of a Low Concentration of CO2 Mist on the Tissue Blood Flow
We compared the differences in blood flow recovery in the ischemic hindlimbs between treatment with high and low CM concentrations. Similar to previous results, treatment with high CM significantly accelerated the blood flow recovery in the ischemic hindlimbs. On the other hand, treatment with low CM only slightly recovered the blood flow in the ischemic hindlimbs (Fig. 6) , suggesting that recovery of the blood flow is enhanced in a CO2 concentrationdependent manner.
Mass Analysis
In order to further investigate the detailed mechanisms of action of CM treatment, we performed a proteomic analysis of the hindlimb muscles at four days after ischemia. Proteins from the adductor muscle in the non-ischemic, UT and CM groups were labeled with 114, 116 and 117 tags, respectively, and 195 proteins were identified when the protein threshold was set at 1.3 to achieve a confidence level above 95%. We also included an additional 1.2-fold change cutoff for the iTRAQ ratio (116/114 0.80 or 1.2) in order to reduce the rate of false-positive results for classifying proteins as upregulated or downregulated. Among the 195 proteins identified, 68 were upregulated and 62 were downregulated by ischemia. Furthermore, 18 of the 68 upregulated proteins were downregulated by inhibited in endothelial cells cultured in medium equilibrated with hypercapnia-associated acidosis 17) . It has also been established that VEGF promotes ischemia-induced angiogenesis [18] [19] [20] . The present data further indicate that the VEGF and FGF-2 expression is induced in the hindlimb skeletal muscles by CO2 mist treatment (Fig. 3) , while the VEGF protein level is increased by CO2 mist (Fig. 4) . The increase in the VEGF expression caused by CO2 mist treatment may, at least partially, contribute to angiogenesis after ischemia. Interestingly, treatment with CO2 gas, as well as mist, significantly increased the VEGF expression on day 14 only in the present study, suggesting that CO2 gas alone may increase the VEGF expression in the chronic phase, although the effect may not be intense.
Previous studies have reported that VEGF stimulates the release of NO from the arterial wall 21) and promotes the recovery of a disturbed endotheliumdependent flow in the ischemic hindlimb. Moreover, the involvement of NO in the angiogenic effects of VEGF has been established in NO-deficient mice 19, 22) . In the current analysis, CO2 mist treatment significantly increased the eNOS mRNA activity, but not its expression (Fig. 4) , as well as the serum NO3 concentration compared with that observed without treatment or treatment with CO2 gas or air mist (Fig. 5-A) . Furthermore, the inhibition of the NOS activity by L-NAME completely inhibited the recovery of the collateral blood flow induced by the CO2 mist (Fig. 5-B) . Furthermore, the CO2 mist significantly increased the LDBF ratio in the iNOS / mice, but not in the eNOS / mice (Fig. 5-C and D) . Taken together, these findings demonstrate that the proangiogenic effects of CO 2 mist are the product of the activation of eNOSmediated signaling resulting from the downstream effects of VEGF. Very interestingly, treatment with CO2 mist using highly concentrated CO2 (100% CO2 gas) significantly accelerated the blood flow recovery in the ischemic hindlimbs. In contrast, treatment with CO2 mist using a low concentration of CO2 only slightly recovered the blood flow in the ischemic hindlimbs (Fig. 6) . These results suggest that blood flow recovery may be enhanced in a CO2 concentration-dependent manner.
In order to further investigate the mechanisms underlying the effects of CO2 mist, we performed a proteomic analysis of the hindlimb muscles four days after ischemia. Interestingly, the levels of 18 of 68 proteins upregulated by ischemia were decreased by CO2 mist treatment. Rap1, a small GTPase, has been shown to regulate multiple basic cellular processes, and there is emerging evidence that Rap1 regulates basic endothelial responses to angiogenic stimulation 23, 24) . In the angiogenesis. Carbonated springs have been used as spa therapy for many years to treat a variety of diseases, particularly in European countries. It is also well known that CO2-enriched water induces peripheral vasodilatation, which increases the cutaneous blood flow 14, 15) . Furthermore, Toriyama et al. reported that the effects of CO2-enriched water on the subcutaneous microcirculation are mediated by peripheral vasodilation resulting from increased parasympathetic and decreased sympathetic nerve activity 16) . Furthermore, a recent study showed that the immersion of ischemic hindlimbs into CO2-enriched water results in a NOdependent increase in collateral blood perfusion in mice in a unilateral hindlimb ischemia model 9) . Hence, highly concentrated CO2 is thought to be useful for treating ischemic diseases. However, devising an artificial CO2-rich bath system is difficult.
Although carbonated spring water has been found to contain more than 1,000 ppm of CO2, it is difficult to constantly maintain the CO2 concentration above 1,000 ppm for hours. In contrast, CO2 dry mist production units can easily produce CO2 concentrations of more than 900,000 ppm 10) . In the present study, we assessed whether treatment with CO2 mist exerts an angiogenic effect in rodent ischemic hindlimbs and investigated the mechanisms responsible for the proangiogenic effects induced by CO2 mist. The main finding of the present study is that percutaneously administered CO2 mist accelerates angiogenesis, compared with no treatment or treatment with CO2 gas or air mist, in mice with hindlimb ischemia.
There are several possible mechanisms for the effects of CO2 mist. For example, the transfer of CO2 across the skin results in beneficial local vasomotor effects without inducing systemic hemodynamic modifications 8) . In the present study, treatment with CO2 mist, but not gas, had vasodilatory effects in rat femoral subcutaneous tissue ( Fig. 1-E to H) . These results suggest that CO2 mist exerts a vasodepressor effect. Furthermore, the CO2 mist significantly increased the oxy-Hb levels and significantly decreased the deoxyHb levels compared with the CO2 gas ( Fig. 1-I and J) . Interestingly, the StO2 levels were also significantly higher in the CO2 mist group than in the CO2 gas group (Fig. 1-L) . These findings suggest that CO2 mist increases the blood flow, consequently shortening the blood capillary transit time, thereby reducing the process of extraction of oxygen from the blood and releasing oxygen more easily.
A recent study demonstrated that the expression levels of potent angiogenic factors, such as VEGF or FGF-2, are increased and endothelial cell apoptosis is present study, the Rap1b level was remarkably increased by ischemia and subsequently decreased by treatment with CO2 mist. Therefore, CO2 mist may regulate excessive Rap1 and ERK activation in the hindlimb muscles, although there are currently no reports concerning the role of Rap1 in skeletal muscle.
On the other hand, we found that, of the 62 proteins downregulated by ischemia, the levels of 21 proteins were increased by CO2 mist treatment. Some of these proteins are enzyme proteins involved in the glycolytic system, such as GAPDH, glucose phosphate isomerase 1, enolase and aldolase A. Therefore, CO2 mist treatment may promote metabolism in ischemic muscles. Oxidative stress occurs when the production of reactive oxygen species (ROS) is enhanced and/or the antioxidant reserve is suppressed. Enhanced ROS production decreases the bioavailability of NO via an oxidative reaction that inactivates NO 25) . Signal et al. provided evidence of a progressive decrease in the SOD and catalase activity in an infarcted rat heart 26) . In addition, the present data show that the SOD2 level is decreased by ischemia and increased by CO2 mist treatment. Therefore, CO2 mist may have antioxidant actions.
Study Limitations
The proteomic analysis identified novel protein candidates regulated by the CO2 mist. However, it could not be determined which molecules are directly regulated by CO2 mist. Therefore, further studies are needed to explore the precise mechanisms underlying CO2 mist-induced angiogenesis.
In conclusion, this study provides the first evidence that CO2 mist promotes angiogenesis after ischemia, at least partially, by increasing the subcutaneous blood flow, as well as the VEGF and NO levels, in ischemic muscles. Hence, CO2 mist therapy is potentially useful for treating patients with PAD.
Supplemental Fig. 1.
A representative Western blot analysis of Rap1b, p-ERK1/2, SOD-2 GAPDH and Tubulin in ischemic muscle tissue specimens at 4 days after ischemia. Rap1b, Ras-associated protein 1B; pERK1/2, phospho-ERK1/2; SOD2, superoxide dismutase 2; GAPDH, glyceraldehyde-3-phosphate dehydrogenate; N, non-ischemic muscle; I-UT, ischemic muscle without treatment; I-CM, ischemic muscle with CO2 mist treatment. 
